Melola Discovery

← Melola Discovery

Open access Journal SINTA 1

ANALYSIS OF NACL-MANNITOL HYDRATION ON RENAL FUNCTION OF HEAD AND NECK CANCER PATIENTS RECEIVING HIGH-DOSE CISPLATIN CHEMOTHERAPY COMBINATION

Folia Medica Indonesiana · Vol. 53 No. 1 (2017) · pp. 64–64

DOI
10.20473/fmi.v53i1.5492
ISSN
2355-8393, 2599-056X
Published
2017-08-15
Publisher
Airlangga University
Language
en
License
creativecommons.org/licenses/by-nc-sa/4.0/

Abstract

Cisplatin is one of platinum cytostatic drug for the medication of solid cancers, one of which is head and neck cancer. Adverse event that resulted during drug treatment was acute or chronic nephrotoxicity. Cisplatin concentration in proximal tubular epithelial cells is about 5 times the serum concentration. Platinum exposure on renal tubular cells bonding covalent complex which stimulate production of inflammatory factors that lead to apoptosis and necrosis cell. Cisplatin nephrotoxicity can be prevented by aggressive hydration or alternate method of administration. The aim of this study was to analyze the effectiveness of NaCl-Mannitol hydration on renal function of head and neck cancer patients receiving cisplatin 100 mg/m2 chemotherapy combination with 5FU or paclitaxel. This was a cohort, prospective, and observational study to analyze renal function of head and neck cancer patients receiving cisplatin 100 mg/m2 chemotherapy combination with 5FU or paclitaxel. Inclusion criteria were BUN 7-18 mg/dl and serum creatinine < 2 mg/dl of any cycle. All patients received infuse NaCl-Mannitol hydration with term that provided in Surgeon Departement of Dr. Soetomo General Hospital. Data obtained were BUN, SCr, and eClCr Cockroft-Gault, each was measured pre- and post-hydration. In cisplatin and 5FU chemotherapy combination value BUN pre-hydration (11,99 + 4,62) mg/dl, value BUN post-hydration (12,14 + 4,74) mg/dl and value serum creatinine pre-hydration (0,97 + 0,34) mg/dl, value serum creatinine post-hydration (1,02 + 0,37) mg/dl. Meanwhile to the combination of cisplatin and paclitaxel chemotherapy, value BUN pre-hydration (10,19 + 2,58) mg/dl, value of BUN post-hydration (10,43 + 2,31) mg/dl and value of serum creatinine post- hydration (0,98 + 0,26) mg/dl. In conclusion, NaCl-Mannitol hydration administration is adequate which is shown by BUN and serum creatinine in pre- and post-hydration data within normal limits.

Keywords

Collaboration network of the authors

40 authors · 90 co-authorship links · 33 across different organisations · showing the 40 most connected

Hover or tap a name to highlight its co-authors. Double-click to open the author's page.

  • University of Brawijaya
  • Universitas Airlangga
  • Rumah Sakit Dokter Soetomo
  • Lambung Mangkurat University
  • Hasanuddin University
  • Japan Tobacco (Japan)
  • Universitas Cokroaminoto Palopo
  • Other organisations
  • Affiliation unknown
  • Different organisations
  • Same organisation
  • Affiliation unknown
  • Thicker line = more joint articles · bigger circle = more articles
Show as table
Co-authorOrganisationJoint articles
Tri ArdyatiUniversity of Brawijaya3
Mariyatul QibtiyahRumah Sakit Dokter Soetomo3
Didik HasmonoUniversitas Airlangga2
Nun ZairinaRumah Sakit Dokter Soetomo2
Muhammad AminuddinRumah Sakit Dokter Soetomo2
Budi SupraptiUniversitas Airlangga2
Hasria AlangHasanuddin University1
Joni KusnadiUniversity of Brawijaya1
Try ArdyatiAffiliation unknown1
Evi OctavianyUniversity of Brawijaya1
Irfan MustafaUniversity of Brawijaya1
Fatchiyah FatchiyahUniversity of Brawijaya1
Bambang SetiawanLambung Mangkurat University1
Takeshi OhtaJapan Tobacco (Japan)1
Vita AgustinaUniversity of Brawijaya1
Muhammad Darwin PrenggonoLambung Mangkurat University1
Ratih Pratiwi SariUniversitas Airlangga1
Aditya Maulana Perdana PutraLambung Mangkurat University1
Mahardian RahmadiUniversitas Airlangga1
Bagyo YanuwiadiUniversity of Brawijaya1
Agus NurrofikUniversity of Brawijaya1
Muhammad FathoniUniversity of Brawijaya1
Nia KurniawanUniversity of Brawijaya1
Miftah Farid AssiddiqyUniversity of Brawijaya1
Abdul Mutholib ShahroniUniversity of Brawijaya1
Agustin Krisna WardaniUniversity of Brawijaya1
Ekwan Nofa WiratnoUniversity of Brawijaya1
Catur RetnaningdyahUniversity of Brawijaya1
Dian AliviyantiUniversity of Brawijaya1
Fitriana RahmawatiUniversity of Brawijaya1
Elok ZubaidahUniversity of Brawijaya1
Eka Pratiwi TenriawaruUniversitas Cokroaminoto Palopo1
Evi SusantiState University of Malang1
Aulanni’am Aulanni’amUniversity of Brawijaya1
A Aulanni’amUniversity of Brawijaya1
Akyunul JannahUniversitas Islam Negeri Maulana Malik Ibrahim1

Affiliations come from OpenAlex; journal OAI-PMH metadata carries none. Authors without an OpenAlex ID are matched by name, which can merge or split people.

Metadata source: OpenAlex API (jurnal SINTA, ADR 0048) https://openalex.org/S4210179714, first harvested 19 Nov 2026, last seen 19 Nov 2026.
Original metadata (oai_dc)
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/"><dc:title xml:lang="en">ANALYSIS OF NACL-MANNITOL HYDRATION ON RENAL FUNCTION OF HEAD AND NECK CANCER PATIENTS RECEIVING HIGH-DOSE CISPLATIN CHEMOTHERAPY COMBINATION</dc:title><dc:creator>Ekanita Desiani</dc:creator><dc:creator>Suharjono Suharjono</dc:creator><dc:creator>Yulistiani Yulistiani</dc:creator><dc:creator>Dwi Hari Susilo</dc:creator><dc:subject>cisplatin nephrotoxicity</dc:subject><dc:subject>head and neck cancer</dc:subject><dc:subject>renal function</dc:subject><dc:subject>serum creatinine</dc:subject><dc:subject>blood urea nitrogen</dc:subject><dc:subject>Cockcroft-Gault formula</dc:subject><dc:subject>5-fluorouracil</dc:subject><dc:subject>paclitaxel</dc:subject><dc:subject>hydration therapy</dc:subject><dc:subject>chemotherapy side effects</dc:subject><dc:subject>renal tubular epithelial cells</dc:subject><dc:subject>apoptosis and necrosis</dc:subject><dc:description xml:lang="en">Cisplatin is one of platinum cytostatic drug for the medication of solid cancers, one of which is head and neck cancer. Adverse event that resulted during drug treatment was acute or chronic nephrotoxicity. Cisplatin concentration in proximal tubular epithelial cells is about 5 times the serum concentration. Platinum exposure on renal tubular cells bonding covalent complex which stimulate production of inflammatory factors that lead to apoptosis and necrosis cell. Cisplatin nephrotoxicity can be prevented by aggressive hydration or alternate method of administration. The aim of this study was to analyze the effectiveness of NaCl-Mannitol hydration on renal function of head and neck cancer patients receiving cisplatin 100 mg/m2 chemotherapy combination with 5FU or paclitaxel. This was a cohort, prospective, and observational study to analyze renal function of head and neck cancer patients receiving cisplatin 100 mg/m2 chemotherapy combination with 5FU or paclitaxel. Inclusion criteria were BUN 7-18 mg/dl and serum creatinine &lt; 2 mg/dl of any cycle. All patients received infuse NaCl-Mannitol hydration with term that provided in Surgeon Departement of Dr. Soetomo General Hospital. Data obtained were BUN, SCr, and eClCr Cockroft-Gault, each was measured pre- and post-hydration. In cisplatin and 5FU chemotherapy combination value BUN pre-hydration (11,99 + 4,62) mg/dl, value BUN post-hydration (12,14 + 4,74) mg/dl and value serum creatinine pre-hydration (0,97 + 0,34) mg/dl, value serum creatinine post-hydration (1,02 + 0,37) mg/dl. Meanwhile to the combination of cisplatin and paclitaxel chemotherapy, value BUN pre-hydration (10,19 + 2,58) mg/dl, value of BUN post-hydration (10,43 + 2,31) mg/dl and value of serum creatinine post- hydration (0,98 + 0,26) mg/dl. In conclusion, NaCl-Mannitol hydration administration is adequate which is shown by BUN and serum creatinine in pre- and post-hydration data within normal limits.</dc:description><dc:publisher>Airlangga University</dc:publisher><dc:date>2017-08-15</dc:date><dc:type>info:eu-repo/semantics/article</dc:type><dc:format>application/pdf</dc:format><dc:identifier>https://doi.org/10.20473/fmi.v53i1.5492</dc:identifier><dc:identifier>10.20473/fmi.v53i1.5492</dc:identifier><dc:source>Folia Medica Indonesiana; Vol 53 No 1 (2017); 64-64</dc:source><dc:source>2355-8393</dc:source><dc:source>2599-056X</dc:source><dc:language>en</dc:language><dc:relation>https://e-journal.unair.ac.id/FMI/article/download/5492/3387</dc:relation><dc:rights>https://creativecommons.org/licenses/by-nc-sa/4.0/</dc:rights></oai_dc:dc>